Literature DB >> 16473510

Amyloids, prions and the inherent infectious nature of misfolded protein aggregates.

Claudio Soto1, Lisbell Estrada, Joaquín Castilla.   

Abstract

Misfolded aggregates present in amyloid fibrils are associated with various diseases known as "protein misfolding" disorders. Among them, prion diseases are unique in that the pathology can be transmitted by an infectious process involving an unprecedented agent known as a "prion". Prions are infectious proteins that can transmit biological information by propagating protein misfolding and aggregation. The molecular mechanism of prion conversion has a striking resemblance to the process of amyloid formation, suggesting that misfolded aggregates have an inherent ability to be transmissible. Intriguing recent data suggest that other protein misfolding disorders might also be transmitted by a prion-like infectious process.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16473510     DOI: 10.1016/j.tibs.2006.01.002

Source DB:  PubMed          Journal:  Trends Biochem Sci        ISSN: 0968-0004            Impact factor:   13.807


  106 in total

Review 1.  Interpreting functional effects of coding variants: challenges in proteome-scale prediction, annotation and assessment.

Authors:  Khader Shameer; Lokesh P Tripathi; Krishna R Kalari; Joel T Dudley; Ramanathan Sowdhamini
Journal:  Brief Bioinform       Date:  2015-10-22       Impact factor: 11.622

Review 2.  Rapidly progressive dementias and the treatment of human prion diseases.

Authors:  Brian S Appleby; Constantine G Lyketsos
Journal:  Expert Opin Pharmacother       Date:  2010-11-23       Impact factor: 3.889

3.  Recognition of conformational changes in beta-lactoglobulin by molecularly imprinted thin films.

Authors:  Nicholas W Turner; Xiao Liu; Sergey A Piletsky; Vladimir Hlady; David W Britt
Journal:  Biomacromolecules       Date:  2007-08-01       Impact factor: 6.988

4.  Early stages of amyloid fibril formation studied by liquid-state NMR: the peptide hormone glucagon.

Authors:  Anna Sigrid Pii Svane; Kasper Jahn; Taru Deva; Anders Malmendal; Daniel Erik Otzen; Jens Dittmer; Niels Chr Nielsen
Journal:  Biophys J       Date:  2008-03-13       Impact factor: 4.033

Review 5.  Insights into intragenic and extragenic effectors of prion propagation using chimeric prion proteins.

Authors:  Heather L True; Tejas Kalastavadi; Elizabeth M H Tank
Journal:  Prion       Date:  2008-04-17       Impact factor: 3.931

6.  Dynamic interactions of Sup35p and PrP prion protein domains modulate aggregate nucleation and seeding.

Authors:  Carmen Krammer; Elisabeth Kremmer; Hermann M Schätzl; Ina Vorberg
Journal:  Prion       Date:  2008 Jul-Sep       Impact factor: 3.931

Review 7.  Disorder-to-order conformational transitions in protein structure and its relationship to disease.

Authors:  Paola Mendoza-Espinosa; Victor García-González; Abel Moreno; Rolando Castillo; Jaime Mas-Oliva
Journal:  Mol Cell Biochem       Date:  2009-04-09       Impact factor: 3.396

Review 8.  A structural overview of the vertebrate prion proteins.

Authors:  Annalisa Pastore; Adriana Zagari
Journal:  Prion       Date:  2007-07-08       Impact factor: 3.931

Review 9.  Inhibition of protein misfolding and aggregation by natural phenolic compounds.

Authors:  Zohra Dhouafli; Karina Cuanalo-Contreras; El Akrem Hayouni; Charles E Mays; Claudio Soto; Ines Moreno-Gonzalez
Journal:  Cell Mol Life Sci       Date:  2018-07-20       Impact factor: 9.261

10.  N-terminal Prion Protein Peptides (PrP(120-144)) Form Parallel In-register β-Sheets via Multiple Nucleation-dependent Pathways.

Authors:  Yiming Wang; Qing Shao; Carol K Hall
Journal:  J Biol Chem       Date:  2016-08-30       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.